Healthy Extracts (HYEX) Net Income towards Common Stockholders (2015 - 2025)
Healthy Extracts (HYEX) reported Net Income towards Common Stockholders of -$269282.0 for Q4 2025, down 38.73% on a YoY basis from -$439475.4 in Q4 2024, and up 41.47% quarter-over-quarter from -$460113.0 in Q3 2025.
Healthy Extracts (HYEX) Net Income towards Common Stockholders (2015 - 2025) Analysis & Trends
Healthy Extracts has reported Net Income towards Common Stockholders for 11 years, with the latest figure at -$269282.0 in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 38.73% year-over-year to -$269282.0; the trailing twelve-month figure through Dec 2025 stood at -$943850.0 (down 416.61% YoY), and the FY2025 full-year result was -$943850.0, down 415.35% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at -$269282.0, up from -$460113.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $85392.0 in Q3 2024, with the low at -$1.3 million in Q2 2023.
- Historically, Net Income towards Common Stockholders has averaged -$308558.0 across 5 years, with a median of -$257751.0 in 2021.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders slumped 787.56% — and 2024, when it jumped 132.74%.
- Healthy Extracts' Net Income towards Common Stockholders stood at -$662057.0 in 2021, then surged by 70.2% to -$197326.0 in 2022, then sank by 63.18% to -$321989.0 in 2023, then soared by 39.72% to -$194110.0 in 2024, then slumped by 38.73% to -$269282.0 in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$269282.0 (Q4 2025), -$460113.0 (Q3 2025), and -$105607.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Healthy Extracts | - | - | 957,429.00 | -269,282.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -269,282.00 |
| Sep 30, 2025 | -460,113.00 |
| Jun 30, 2025 | -105,607.00 |
| Mar 31, 2025 | -108,848.00 |
| Dec 31, 2024 | -194,110.00 |
| Sep 30, 2024 | 85,392.00 |
| Jun 30, 2024 | -11,908.00 |
| Mar 31, 2024 | -62,073.00 |
| Dec 31, 2023 | -321,989.00 |
| Sep 30, 2023 | -260,793.00 |
| Jun 30, 2023 | -1.26 Mn |
| Mar 31, 2023 | -405,188.00 |
| Dec 31, 2022 | -197,326.00 |
| Sep 30, 2022 | -54,466.00 |
| Jun 30, 2022 | -614,146.00 |
| Mar 31, 2022 | -45,652.00 |
| Dec 31, 2021 | -662,057.00 |
| Sep 30, 2021 | -385,315.00 |
| Jun 30, 2021 | -254,709.00 |
| Mar 31, 2021 | -587,096.00 |